BPG is committed to discovery and dissemination of knowledge
Number of total visits
2741229
Number of visits today
860
Number of downloads
2012819
MEMBERSHIP
Cited by in F6Publishing
Number
Citing Articles
1
Theofilis P, Vordoni A, Kalaitzidis RG. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations. World J Gastroenterol 2022; 28(39): 5691-5706 [DOI: 10.3748/wjg.v28.i39.5691 ] [ Cited by in CrossRef: 3 ] [ Cited by in F6Publishing: 3 ] [ Article Influence: 3.0 ] [ Reference Citation Analysis ]
2
Zixin Y , Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R, Dongsheng O. TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review. Front Pharmacol 2022;13 :929262. [DOI: 10.3389/fphar.2022.929262 ] [ Reference Citation Analysis ]
3
Hsu BG , Wang CH , Lin YL , Lai YH , Tsai JP . Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients. Toxins (Basel) 2022;14 :526. [PMID: 36006188 DOI: 10.3390/toxins14080526 ] [ Cited by in F6Publishing: 1 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345